Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Unusually active option classes on open February 3rd » 09:40
02/03/23
02/03
09:40
02/03/23
09:40
BKLN

Invesco Senior Loan ETF

$21.20 /

+ (+0.00%)

, JWN

Nordstrom

$21.14 /

-0.01 (-0.05%)

, KOLD

ProShares UltraShort Bloomberg Natural Gas

$64.52 /

-0.15 (-0.23%)

, ALB

Albemarle

$290.17 /

+ (+0.00%)

, T

AT&T

$20.28 /

+ (+0.00%)

, AI

C3.ai

$21.94 /

-0.025 (-0.11%)

, SLV

iShares Silver Trust

$21.57 /

+ (+0.00%)

, BHC

Bausch Health

$7.91 /

+ (+0.00%)

, GOLD

Barrick Gold

$19.40 /

+ (+0.00%)

, META

Meta Platforms

$188.78 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Powershares Loan ETF (BKLN), Nordstrom (JWN), ProShares UltraShort DJ-UBS Natural Gas (KOLD), Albemarle (ALB), AT&T (T), C3 AI (AI), iShares Silver Trust (SLV), Bausch Health (BHC), Barrick Gold (GOLD), and Meta Platforms (Facebook) (META).

ShowHide Related Items >><<
T AT&T
$20.28 /

+ (+0.00%)

META Meta Platforms
$188.78 /

+ (+0.00%)

KOLD ProShares UltraShort Bloomberg Natural Gas
$64.52 /

-0.15 (-0.23%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

GOLD Barrick Gold
$19.40 /

+ (+0.00%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

ALB Albemarle
$290.17 /

+ (+0.00%)

AI C3.ai
$21.94 /

-0.025 (-0.11%)

BKLN Invesco Senior Loan ETF
$21.20 /

+ (+0.00%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

02/03/23 William Blair
Nordstrom performance 'begs for an activist role,' says William Blair
02/03/23 Gordon Haskett
Nordstrom upgraded to Hold from Reduce at Gordon Haskett
01/30/23 Goldman Sachs
Nordstrom initiated with a Neutral at Goldman Sachs
01/20/23 Deutsche Bank
Nordstrom price target lowered to $17 from $21 at Deutsche Bank
KOLD ProShares UltraShort Bloomberg Natural Gas
$64.52 /

-0.15 (-0.23%)

ALB Albemarle
$290.17 /

+ (+0.00%)

01/31/23 Credit Suisse
Albemarle price target raised to $240 from $200 at Credit Suisse
01/26/23 Mizuho
Albemarle price target raised to $325 from $300 at Mizuho
01/26/23 Piper Sandler
Albemarle initiated with Overweight, $310 target at Piper Sandler
01/25/23 Piper Sandler
Albemarle initiated with an Overweight at Piper Sandler
T AT&T
$20.28 /

+ (+0.00%)

01/26/23 Cowen
AT&T price target raised to $25 from $24 at Cowen
01/24/23 Citi
AT&T price target raised to $22 from $20 at Citi
01/13/23 Truist
American Tower price target lowered to $275 from $325 at Truist
01/10/23 Citi
Citi adds AT&T, Equinix to 'Positive Catalyst Watch List'
AI C3.ai
$21.94 /

-0.025 (-0.11%)

02/02/23 DA Davidson
C3.ai initiated with a Buy at DA Davidson
12/08/22 Morgan Stanley
C3.ai price target lowered to $12 from $13 at Morgan Stanley
12/08/22 Piper Sandler
C3.ai price target lowered to $13 from $14 at Piper Sandler
12/08/22 Deutsche Bank
C3.ai price target lowered to $11 from $13 at Deutsche Bank
SLV iShares Silver Trust
$21.57 /

+ (+0.00%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

11/18/22 BofA
Generic guidance for Bausch Health's Xifaxan 'not a surprise,' says BofA
11/17/22 Evercore ISI
FDA made 'key change' to guidance on generic Xifaxan, says Evercore ISI
10/20/22 Jefferies
Bausch Health assumed with a Hold at Jefferies
09/09/22 Piper Sandler
Bausch Health price target lowered to $6 from $7 at Piper Sandler
GOLD Barrick Gold
$19.40 /

+ (+0.00%)

01/30/23 Barclays
Barrick Gold price target raised to $26 from $23 at Barclays
01/13/23 National Bank
Barrick Gold price target raised to C$30 from C$25 at National Bank
11/29/22 National Bank
Barrick Gold price target raised to C$25 from C$24 at National Bank
11/21/22 RBC Capital
Barrick Gold price target lowered to $20 from $27 at RBC Capital
META Meta Platforms
$188.78 /

+ (+0.00%)

02/03/23 DA Davidson
Amazon.com price target raised to $134 from $114 at DA Davidson
02/03/23 HSBC
Meta Platforms downgraded to Reduce from Hold at HSBC
02/03/23 DZ Bank
Meta Platforms upgraded to Hold from Sell at DZ Bank
02/02/23 Deutsche Bank
Meta Platforms price target raised to $200 from $125 at Deutsche Bank
T AT&T
$20.28 /

+ (+0.00%)

META Meta Platforms
$188.78 /

+ (+0.00%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

GOLD Barrick Gold
$19.40 /

+ (+0.00%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

ALB Albemarle
$290.17 /

+ (+0.00%)

AI C3.ai
$21.94 /

-0.025 (-0.11%)

T AT&T
$20.28 /

+ (+0.00%)

META Meta Platforms
$188.78 /

+ (+0.00%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

GOLD Barrick Gold
$19.40 /

+ (+0.00%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

ALB Albemarle
$290.17 /

+ (+0.00%)

T AT&T
$20.28 /

+ (+0.00%)

META Meta Platforms
$188.78 /

+ (+0.00%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

ALB Albemarle
$290.17 /

+ (+0.00%)

AI C3.ai
$21.94 /

-0.025 (-0.11%)

T AT&T
$20.28 /

+ (+0.00%)

SLV iShares Silver Trust
$21.57 /

+ (+0.00%)

META Meta Platforms
$188.78 /

+ (+0.00%)

KOLD ProShares UltraShort Bloomberg Natural Gas
$64.52 /

-0.15 (-0.23%)

JWN Nordstrom
$21.14 /

-0.01 (-0.05%)

GOLD Barrick Gold
$19.40 /

+ (+0.00%)

BKLN Invesco Senior Loan ETF
$21.20 /

+ (+0.00%)

BHC Bausch Health
$7.91 /

+ (+0.00%)

ALB Albemarle
$290.17 /

+ (+0.00%)

AI C3.ai
$21.94 /

-0.025 (-0.11%)

Over a week ago
Recommendations
Albemarle price target raised to $240 from $200 at Credit Suisse » 06:33
01/31/23
01/31
06:33
01/31/23
06:33
ALB

Albemarle

/

+

Credit Suisse analyst…

Credit Suisse analyst John Roberts raised the firm's price target on Albemarle to $240 from $200 and keeps an Underperform rating on the shares. The firm cites uncertain lithium pricing but solid volume growth outlook.

ShowHide Related Items >><<
ALB Albemarle
/

+

ALB Albemarle
/

+

01/26/23 Mizuho
Albemarle price target raised to $325 from $300 at Mizuho
01/26/23 Piper Sandler
Albemarle initiated with Overweight, $310 target at Piper Sandler
01/25/23 Piper Sandler
Albemarle initiated with an Overweight at Piper Sandler
01/25/23 Deutsche Bank
Albemarle price target raised to $305 from $290 at Deutsche Bank
ALB Albemarle
/

+

ALB Albemarle
/

+

ALB Albemarle
/

+

ALB Albemarle
/

+

Hot Stocks
Albemarle launches Ketjen, a wholly owned subsidiary » 16:22
01/30/23
01/30
16:22
01/30/23
16:22
ALB

Albemarle

$271.90 /

-9.79 (-3.48%)

Albemarle announced the…

Albemarle announced the official brand launch of Ketjen, its wholly owned subsidiary that crafts tailored, advanced catalyst solutions for the petrochemical, refining and specialty chemicals industries. The company shared the new name of its catalysts business in November 2022 after announcing plans to operate the business as a subsidiary. Headquartered in Houston, Texas, Ketjen will collaborate with customers in the petrochemical, refining and specialty chemical industries across three divisions, Fluidized Catalytic Cracking, Clean Fuels and Hydroprocessing Catalysts, and Performance Catalyst & Curative Solutions. Albemarle's existing advanced catalyst solutions team will lead Ketjen operations.

ShowHide Related Items >><<
ALB Albemarle
$271.90 /

-9.79 (-3.48%)

ALB Albemarle
$271.90 /

-9.79 (-3.48%)

01/26/23 Mizuho
Albemarle price target raised to $325 from $300 at Mizuho
01/26/23 Piper Sandler
Albemarle initiated with Overweight, $310 target at Piper Sandler
01/25/23 Piper Sandler
Albemarle initiated with an Overweight at Piper Sandler
01/25/23 Deutsche Bank
Albemarle price target raised to $305 from $290 at Deutsche Bank
ALB Albemarle
$271.90 /

-9.79 (-3.48%)

ALB Albemarle
$271.90 /

-9.79 (-3.48%)

ALB Albemarle
$271.90 /

-9.79 (-3.48%)

ALB Albemarle
$271.90 /

-9.79 (-3.48%)

Recommendations
Albemarle price target raised to $325 from $300 at Mizuho » 06:48
01/26/23
01/26
06:48
01/26/23
06:48
ALB

Albemarle

$270.99 /

+6.28 (+2.37%)

Mizuho analyst…

Mizuho analyst Christopher Parkinson raised the firm's price target on Albemarle to $325 from $300 and keeps a Neutral rating on the shares. The analyst left the company's strategic update more constructive on 2023 estimates. The firm is still bullish on intermediate-term demand, but sees Albemarle putting forth a higher bar verses what it anticipated into the event.

ShowHide Related Items >><<
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

01/26/23 Piper Sandler
Albemarle initiated with Overweight, $310 target at Piper Sandler
01/25/23 Piper Sandler
Albemarle initiated with an Overweight at Piper Sandler
01/25/23 Deutsche Bank
Albemarle price target raised to $305 from $290 at Deutsche Bank
01/25/23 RBC Capital
Albemarle price target raised to $362 from $340 at RBC Capital
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

Initiation
Albemarle initiated with Overweight, $310 target at Piper Sandler » 06:02
01/26/23
01/26
06:02
01/26/23
06:02
ALB

Albemarle

$270.99 /

+6.28 (+2.37%)

Piper Sandler analyst…

Piper Sandler analyst Charles Neivert last night initiated coverage of Albemarle with an Overweight rating and $310 price target. The analyst believes the company is transitioning from a cyclical to one more associated with growth, which deserves a multiple more in line with its historical performance. Albemarle is basically a lithium pure play on a going forward basis, the analyst tells investors in a research note. Not only is lithium a vast proportion of the overall earnings of Albemarle, but it also represents the bulk of the earnings upside, says Piper.

ShowHide Related Items >><<
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

01/25/23 Piper Sandler
Albemarle initiated with an Overweight at Piper Sandler
01/25/23 Deutsche Bank
Albemarle price target raised to $305 from $290 at Deutsche Bank
01/25/23 RBC Capital
Albemarle price target raised to $362 from $340 at RBC Capital
01/25/23 Oppenheimer
Albemarle price target raised to $497 from $461 at Oppenheimer
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

Initiation
Albemarle initiated with an Overweight at Piper Sandler » 16:33
01/25/23
01/25
16:33
01/25/23
16:33
ALB

Albemarle

$270.99 /

+6.28 (+2.37%)

Piper Sandler analyst…

Piper Sandler analyst Charles Neivert initiated coverage of Albemarle with an Overweight rating and $310 price target.

ShowHide Related Items >><<
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

01/25/23 Deutsche Bank
Albemarle price target raised to $305 from $290 at Deutsche Bank
01/25/23 RBC Capital
Albemarle price target raised to $362 from $340 at RBC Capital
01/25/23 Oppenheimer
Albemarle price target raised to $497 from $461 at Oppenheimer
01/25/23 Baird
Albemarle price target raised to $305 from $298 at Baird
ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

ALB Albemarle
$270.99 /

+6.28 (+2.37%)

Recommendations
Albemarle price target raised to $305 from $290 at Deutsche Bank » 10:24
01/25/23
01/25
10:24
01/25/23
10:24
ALB

Albemarle

$262.47 /

-2.24 (-0.85%)

Deutsche Bank analyst…

Deutsche Bank analyst David Begleiter raised the firm's price target on Albemarle to $305 from $290 and keeps a Buy rating on the shares. The analyst says the company had a strong 2023 strategic update with EBITDA guidance 4% ahead of consensus.

ShowHide Related Items >><<
ALB Albemarle
$262.47 /

-2.24 (-0.85%)

ALB Albemarle
$262.47 /

-2.24 (-0.85%)

01/25/23 RBC Capital
Albemarle price target raised to $362 from $340 at RBC Capital
01/25/23 Oppenheimer
Albemarle price target raised to $497 from $461 at Oppenheimer
01/25/23 Baird
Albemarle price target raised to $305 from $298 at Baird
01/24/23 Loop Capital
Albemarle strategic update 'very constructive', says Loop Capital
ALB Albemarle
$262.47 /

-2.24 (-0.85%)

ALB Albemarle
$262.47 /

-2.24 (-0.85%)

ALB Albemarle
$262.47 /

-2.24 (-0.85%)

ALB Albemarle
$262.47 /

-2.24 (-0.85%)

Recommendations
Albemarle price target raised to $362 from $340 at RBC Capital » 09:26
01/25/23
01/25
09:26
01/25/23
09:26
ALB

Albemarle

$264.65 /

+4.02 (+1.54%)

RBC Capital analyst Arun…

RBC Capital analyst Arun Viswanathan raised the firm's price target on Albemarle to $362 from $340 and keeps an Outperform rating on the shares after its Q4 pre-announcement and medium-term sales growth update. The analyst is positive on the company's growth prospects but cautious on near-term volatility in lithium prices given its exposure to index-based prices and potential demand headwinds from macro weakness. The firm adds however that longer-term, Albemarle is well positioned to serve the EV and sustainable energy high-growth markets.

ShowHide Related Items >><<
ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

01/25/23 Oppenheimer
Albemarle price target raised to $497 from $461 at Oppenheimer
01/25/23 Baird
Albemarle price target raised to $305 from $298 at Baird
01/24/23 Loop Capital
Albemarle strategic update 'very constructive', says Loop Capital
01/17/23 Deutsche Bank
Albemarle named short-term buy idea at Deutsche Bank
ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

Recommendations
Albemarle price target raised to $497 from $461 at Oppenheimer » 08:51
01/25/23
01/25
08:51
01/25/23
08:51
ALB

Albemarle

$264.65 /

+4.02 (+1.54%)

Oppenheimer analyst Colin…

Oppenheimer analyst Colin Rusch raised the firm's price target on Albemarle to $497 from $461 and keeps an Outperform rating on the shares after the company provided an update on its strategic outlook. The firm notes that despite some lithium inventory build in China in Q1 2023, demand for the balance of the year and through the end of the decade appears to be in excess of supply. Oppenheimer views Albemarle as a leader in lithium quality, and points out that the company is growing sustainably at scale as it ramps while continuing to be free cash flow positive.

ShowHide Related Items >><<
ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

01/25/23 Baird
Albemarle price target raised to $305 from $298 at Baird
01/24/23 Loop Capital
Albemarle strategic update 'very constructive', says Loop Capital
01/17/23 Deutsche Bank
Albemarle named short-term buy idea at Deutsche Bank
01/10/23 Deutsche Bank
Albemarle price target lowered to $290 from $325 at Deutsche Bank
ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

ALB Albemarle
$264.65 /

+4.02 (+1.54%)

Recommendations
Albemarle price target raised to $305 from $298 at Baird » 06:51
01/25/23
01/25
06:51
01/25/23
06:51
ALB

Albemarle

/

+

Baird analyst Ben Kallo…

Baird analyst Ben Kallo raised the firm's price target on Albemarle to $305 from $298 and keeps a Neutral rating on the shares. The analyst said strong 2022 results and a favorable five-year outlook are driven by continued high demand for EV inputs which are expected to uphold lithium prices in the near term.

ShowHide Related Items >><<
ALB Albemarle
/

+

ALB Albemarle
/

+

01/24/23 Loop Capital
Albemarle strategic update 'very constructive', says Loop Capital
01/17/23 Deutsche Bank
Albemarle named short-term buy idea at Deutsche Bank
01/10/23 Deutsche Bank
Albemarle price target lowered to $290 from $325 at Deutsche Bank
01/04/23 Vertical Research
Albemarle upgraded to Buy from Hold at Vertical Research
ALB Albemarle
/

+

ALB Albemarle
/

+

ALB Albemarle
/

+

ALB Albemarle
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.